WB
Product Image
Sold Out
Price unavailable

Product Details

Manufacturer
Atlas Antibodies

About this product

Anti-POU2F3 Antibody

by Atlas Antibodies · SKU HPA019652IHC

Overview

This antibody targets human POU2F3 (POU class 2 homeobox 3), a transcription factor involved in epithelial cell differentiation and gene regulation. It is generated against a defined POU2F3-derived immunogen sequence and forms part of the Atlas Antibodies Triple A Polyclonals collection. According to the manufacturer, validation is limited to immunohistochemistry (IHC).

Highlights

  • Specific for human POU class 2 homeobox 3 (POU2F3)
  • Validated application: immunohistochemistry (IHC)
  • Defined peptide immunogen
  • Supplied in a glycerol-based phosphate buffer

At-a-glance

Target protein
POU2F3 (POU class 2 homeobox 3)
Host species
Rabbit
Clonality
Polyclonal
Validated applications
Immunohistochemistry (IHC)
Immunogen sequence
LESMHTDIKMSGDVADSTDARSTLSQVEPGNDRNGLDFNRQIKTEDLSDSLQQTLSHRPCHLSQGPAMMSGNQMSGLNASPCQDMASLHPLQQLVLVPGHLQSVSQFLLSQTQP
Buffer composition
40% glycerol, PBS (pH 7.2), 0.02% sodium azide
Condition
New / Unused — The product is only validated for IHC application

Applications

This antibody is suitable for immunohistochemical detection of POU2F3 in human tissue sections. It may support studies of epithelial lineage specification, transcriptional regulation, and cell differentiation. No validation is reported for applications beyond IHC.

Sustainability

By rehoming surplus lab products, this listing supports waste reduction and resource efficiency.

Related Products

What Our Clients Say

Supporting innovation at leading research companies

RNAnalytics

RNAnalytics

Leading The Way In Gene Therapy Analytics

As a startup focused on developing analytical toolkits for LNP characterization, RNAnalytics operates under tight budget constraints while striving to maintain a fully stocked lab with high-quality materials. Sustainability is also a core pillar of our operations, pushing us to make environmentally conscious decisions wherever possible....